CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 30, 2022	Oct. 31, 2021
Cash flows from operating activities:
Net earnings	$ 772,911	$ 723,396
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
Depreciation and amortization	157,410	145,897
Loss on disposal/impairment of assets	5,738	887
Amortization of deferred lease incentives	(2,442)	(3,345)
Non-cash lease expense	169,602	159,757
Deferred income taxes	(10,494)	(11,440)
Tax benefit related to stock-based awards	11,172	10,838
Stock-based compensation expense	67,797	70,566
Other	272	4
Changes in:
Accounts receivable	5,288	4,941
Merchandise inventories	(443,812)	(264,094)
Prepaid expenses and other assets	(39,737)	(10,078)
Accounts payable	98,103	74,181
Accrued expenses and other liabilities	(34,157)	24,400
Gift card and other deferred revenue	42,005	58,189
Operating lease liabilities	(177,855)	(164,569)
Income taxes payable	(33,276)	(31,191)
Net cash provided by operating activities	588,525	788,339
Cash flows from investing activities:
Purchases of property and equipment	(234,378)	(141,010)
Other	100	97
Net cash used in investing activities	(234,278)	(140,913)
Cash flows from financing activities:
Repurchases of common stock	(840,955)	(652,699)
Payment of dividends	(165,254)	(135,201)
Tax withholdings related to stock-based awards	(80,431)	(102,482)
Repayment of long-term debt	0	(300,000)
Debt issuance costs	0	(777)
Net cash used in financing activities	(1,086,640)	(1,191,159)
Effect of exchange rates on cash and cash equivalents	(4,887)	294
Net decrease in cash and cash equivalents	(737,280)	(543,439)
Cash and cash equivalents at beginning of period	850,338	1,200,337
Cash and cash equivalents at end of period	$ 113,058	$ 656,898